Clinical Trials Directory

Trials / Completed

CompletedNCT01625533

Safety and Efficacy Study of Dual-axis Rotational Versus Standard Coronary Angiography

Randomized Study on the Safety and Efficacy of Dual-axis Rotational Versus Standard Coronary Angiography

Status
Completed
Phase
Study type
Observational
Enrollment
576 (actual)
Sponsor
General Hospital of Chinese Armed Police Forces · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the clinical safety and efficacy of dual-axis rotational coronary angiography (DARCA) in the diagnosis of coronary artery disease by directly comparing it to standard coronary angiography (SA).

Detailed description

Dual-axis rotational coronary angiography (DARCA) was developed as an innovative adaptation of rotational angiography (RA), but it requires a longer coronary injection compared to standard coronary angiography (SA). The risk of complications from the contrast agent (such as discomfort, warmth, pain, hypotension and bradycardia) is increased with the use of DARCA. It remains to be evaluated whether this approach is also suitable for coronary angiography, especially using in the patients with complex coronary lesions. Previous studies revealed promising results, but the number of patients included did not provide sufficient statistical power to allow a valid comparison of DARCA with SA. The purpose of this study is to evaluate the feasibility, safety, clinical tolerance, and hemodynamic effect of DARCA in comparison to the well-established SA.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard Coronary AngiographyUsing standard coronary angiography (SA) for the diagnosis of coronary artery disease.
PROCEDUREDual-axis Rotational Coronary AngiographyUsing dual-axis rotational coronary angiography (DARCA) for the diagnosis of coronary artery disease.

Timeline

Start date
2012-06-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2012-06-21
Last updated
2015-06-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01625533. Inclusion in this directory is not an endorsement.